Insider · CIK 0001862050
HUSSAIN IQBAL J
officer
Files at CNTA (Centessa Pharmaceuticals plc). First filing Dec 17, 2024, latest Dec 17, 2024.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $1.3M sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Side | Company | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 30Weak | sell 510b5-1 | CNTA Centessa Pharmaceuticals plc | $1.3M | 77,705 | -38% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | CNTA Centessa Pharmaceuticals plc | FTax withholding Ordinary Shares | -7,520 | $16.35 | $123k | 118,265 | Dec 31, 2024 |
| Dec 16, 2024 | CNTA Centessa Pharmaceuticals plc | MOption exercise Ordinary Shares10b5-1 | +6,000 | $5.84 | $35k | 203,490 | Dec 17, 2024 |
| Dec 16, 2024 | CNTA Centessa Pharmaceuticals plc | SOpen-market sale Ordinary Shares10b5-1 | -77,705 | $16.39 | $1.3M | 125,785 | Dec 17, 2024 |
| Dec 16, 2024 | CNTA Centessa Pharmaceuticals plc | MOption exercise Share Option (right to buy)derivative10b5-1 | -6,000 | $0.00 | $0 | 327,559 | Dec 17, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.